Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

ALDX

Aldeyra Therapeutics, Inc.

Tremor tracks 1 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

  • ALDXAldeyra Therapeutics, Inc.
    0Calm

    A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma

    Signing up patientsPhase 320 patientsMain results: Dec 2026

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

0 sales (0 not pre-planned) · 1 purchase

  • Brady Todd CPresident and CEO · Jun 3, 2026Bought 250,000 sharesabout $418 thousand ·

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • Quarterly reportQuarterly report (10-Q)Nov 5, 2026
  • Shared information with investors; Other newsNews report (8-K)Sep 29, 2026
  • Quarterly reportQuarterly report (10-Q)Aug 6, 2026
  • Signed a major agreementNews report (8-K)Jul 30, 2026
  • Other newsNews report (8-K)Jul 15, 2026

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.
An executive or board member joined or left; Shared information with investorsNews report (8-K)
Jun 10, 2026